Faropenem

DB12190InvestigationalSmall molecule

Faropenem has been used in trials studying the treatment of Tuberculosis, Pulmonary Tuberculosis, and Community Acquired Pneumonia.

Chemical structure of Faropenem
Mechanism
Curator reviewed
Formula / weight
C12H15NO5S · 285.316 g/mol (avg)

Resolves to

Compound
UNIIF52Y83BGH3CAS106560-14-9ChEMBLCHEMBL556262ChEBI51257PubChem65894
Clinical / RWD
ATCJ01DI03
Structure
InChIKeyHGGAKXAHAYOLDJ-FHZUQPTBSA-NSMILES[H][C@]12SC([C@H]3CCCO3)=C(N1C(=O)[C@@H]2[C@@H](C)O)C(O)=O
Targets
P0AC13folP

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 6 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Faropenem, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In